Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy

Cure Cancer Worldwide, LLC300 enrolled

Overview

Observational Study of Pain Reduction in Late Stage Cancer Patients Receiving Low-Dose Chemotherapy

Observational Study of Pain Reduction in Late Stage Cancer Patients who are Receiving Low-Dose Chemotherapy (Metabolic Targeting)

Study Type

OBSERVATIONAL

Enrollment

300

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patient requests to be included in this study Exclusion Criteria: * Patient does not request to be included in this study

Pain Level Self Assessment

From enrollment in study to termination of study (August 2020)

Time frame: 5 years

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.